Corcept Therapeutics

Recent executive movements at Corcept Therapeutics

Atabak Mokari has joined the company as Chief Financial Officer  (news posted on March 2 2021).
Charles Robb who was Chief Financial Officer, becomes Chief Business Officer  (news posted on March 2 2021).
Gillian Cannon has joined the company as Director  (news posted on November 24 2020).

Create an alert
to follow the executive moves at Corcept Therapeutics.

Corcept Therapeutics is one of the...

• Russell 3000.

Most searched biographies at Corcept Therapeutics

• Joseph Belanoff, Chief Executive Officer & Director
• Leonard Baker, Director
• David Mahoney, Director

Click on an executive to view his biography >

Latest M&A news in Biotechnology.

Bio-Techne has announced the acquisition of Asuragen (posted on Mar 4, 2021).
Roivant Sciences has announced the acquisition of Silicon Therapeutics (posted on Feb 26, 2021).
Merck has announced the acquisition of Pandion Therapeutics (posted on Feb 26, 2021).

Other contacts in the Biotechnology industry

• Tal Zaks - Non-Executive Director at Adaptimmune Therapeutics
• Chandra Leo - Director at Gynesonics
• Stephen Hoge - Director at Axcella Health

Learn more about the Biotechnology industry >

Latest news about Corcept Therapeutics

Corcept Therapeutics on Wikipedia, Google News & Yahoo Finance

Corcept Therapeutics on LinkedIn, Twitter & YouTube

Corcept Therapeutics has 1,577 competitors including Biogen (United States (USA)), Neptune Wellness Solutions (Canada) and Eurofins (France).

Contact by email its executives including Joseph Belanoff

Call Corcept Therapeutics at +1 650....

View the org chart

Register to receive your alert

Report an error